-+ 0.00%
-+ 0.00%
-+ 0.00%

ANIXA BIOSCIENCES AND MOFFITT CANCER CENTER ADVANCE OVARIAN CANCER CAR-T CLINICAL TRIAL TO HIGHEST DOSE LEVEL TO DATE

Reuters·07/06/2026 12:30:02

Please log in to view news